Rengasil — Competitive Intelligence Brief

Rengasil (PIRPROFEN) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: pirprofen. Area: Immunology.

marketed pirprofen Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2 Immunology Small molecule

Target snapshot

Rengasil (PIRPROFEN).

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Rengasil TARGET	PIRPROFEN		marketed	pirprofen	Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2	1987-01-01
MOFEZOLAC	MOFEZOLAC		marketed	mofezolac	Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Prostaglandin G/H synthase 1	1994-01-01
(+)-Ketoprofen	DEXKETOPROFEN		marketed	Nonsteroidal Anti-inflammatory Drug [EPC]	Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2	1994-01-01
Profenol	SUPROFEN	Novartis	marketed	suprofen	Cytochrome P450 2C9, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2	1988-01-01
Ro 205720	CARPROFEN	Roche	marketed	carprofen	Complement C5, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2	1987-01-01
Zomiperac	ZOMEPIRAC		marketed	zomepirac	Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase	1980-01-01
Bactocill In Plastic Container	OXACILLIN	Apothecon	marketed		Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2	1971-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (pirprofen class)

1. · 1 drug in this class